Royalty Pharma Sub-Manager, LLC quarter change: USA Bonds: Other Debt, Sold out
In other debt filed by principal amount (debentures, bonds) (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, Royalty Pharma Sub-Manager, LLC opened 0 positions, added to 0, reduced 0, sold out of 0 and left 0 unchanged.
Two Form 13F-HR filings compared (SEC CIK 2081668): 2026-03-31 (filed 2026-08-21) and 2026-06-30 (filed 2026-08-21). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Marest Capital, LLC | United States | $0.173B | 29 |
| Dynamic Wealth Strategies, LLC | United States | $0.173B | 288 |
| Kurv Investment Management LLC | United States | $0.173B | 62 |
| Capital Today Evergreen Fund, L.P. | Cayman Islands | $0.173B | 3 |
| PETERSON WEALTH MANAGEMENT | United States | $0.172B | 166 |
| Godshalk Welsh Capital Management, Inc. | United States | $0.172B | 129 |
| Forbes Financial Planning, Inc. | United States | $0.173B | 38 |
| Innovative Asset Advisors Group, LLC | United States | $0.173B | 1,040 |
| Saxony Capital Management, LLC | United States | $0.172B | 161 |
| Tiptree Advisors, LLC | United States | $0.172B | 22 |